SMPD3 and Alzheimer disease: In male 5xFAD mice, pharmacological inhibition or genetic deficiency of neutral sphingomyelinase 2 (nSMase2), an enzyme generating ceramide and critical for EV secretion, improved AD pathology, but this was not the case for female mice [13].